MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/13/2026, 06:31 PM (Berlin time), refresh in progress.

Scilex Holding Company Stock

Scilex Holding Company

SCLXNASDAQMarkt
US$2.91
+3.9% today

Company data

Sector
Healthcare
Industry
Drug Manufacturers - General
Country
United States
CEO
Henry H. Ji
Employees
34
Market cap
$25 M
IPO
05/03/2021

Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to…

Scilex Holding Company stock: price history

13/10/25-80.3 %13/10/26

1D

+3.9%

1W

-26.5%

1M

-41.9%

6M

-50.9%

YTD

-76.1%

1Y

-80.3%

2Y

-89.5%

5Y

-99.2%

10Y

–

Next earnings date

Next earnings date

02/12/2026 (in 46 days)

Volatility around earnings

~25% stronger price swings than usual

Ask the agents about Scilex Holding Company

Analyst assessment of Scilex Holding Company

0

STRONG BUY

1

BUY

1

HOLD

0

SELL

0

STRONG SELL

2

TOTAL · Buy

As of: 11/04/2025

ANALYST FIRMRATINGACTIONDATE
D. Boral CapitalBuy → Holddowngrade11/04/2025 (older than 12 months)
D. Boral CapitalBuymaintain02/04/2025 (older than 12 months)
D. Boral CapitalBuymaintain28/02/2025 (older than 12 months)
HC Wainwright & Co.Buymaintain21/10/2024 (older than 12 months)
HC Wainwright & Co.Buymaintain17/06/2024 (older than 12 months)
HC Wainwright & Co.Buymaintain11/06/2024 (older than 12 months)
HC Wainwright & Co.Buymaintain23/05/2024 (older than 12 months)
HC Wainwright & Co.Buymaintain03/05/2024 (older than 12 months)

Scilex Holding Company stock metrics

P/E

-0.04

P/B

-0.07

EV/EBITDA

-0.33

RETURN ON EQUITY

36.8%

NET MARGIN

-1,485.2%

DEBT/EQUITY

-0.31

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

88.3%

FLOAT SHARES

7,500,542

AVG. DAILY VOLUME (30D)

40,208

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

SCLX Stock Acquisition JV LLC

10% ownerJ500,000–Spontaneous07/07/2026

Scilex Holding Co

10% ownerJ7,034,737–Spontaneous26/06/2026

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
GAMMA Investing LLC0-11630/09/2026
Versant Capital Management, Inc0-76130/09/2026
VANGUARD CAPITAL MANAGEMENT LLC301,292+37,24230/06/2026
BlackRock, Inc.109,417+6,62130/06/2026
VANGUARD FIDUCIARY TRUST CO45,822+6,16430/06/2026
Page 1 / 3

Dividends & Stock splits

DATERATIO
15/04/20251:35

Comparable stocks

Frequently asked questions about Scilex Holding Company stock

What does Scilex Holding Company do?

Scilex Holding Company is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United States.

The CEO is Henry H. Ji, the company employs around 34 people.

The IPO was on 05/03/2021; the stock trades on NASDAQ under the ticker SCLX.

What do analysts say about Scilex Holding Company stock?

2 analysts rate the stock, the consensus is Buy (as of 11/04/2025).

This is an external assessment, not a statement by Market Jury.

When does Scilex Holding Company report next?

The next earnings date is 02/12/2026.

Around past earnings, price swings were roughly 25% stronger than usual.

Does Scilex Holding Company pay a dividend?

No, Scilex Holding Company currently does not pay a dividend.

Which stocks are comparable to Scilex Holding Company?

Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences, Pfizer and Bristol-Myers Squibb Company.

How can I get Scilex Holding Company stock analyzed?

Clicking "Analyze stock" lets five strategies assess Scilex Holding Company against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.